CClinicalTrials.gg
RecruitingNCT03578003Updated Nov 14, 2025

Morning Bright Light to Improve Sleep Quality in Veterans

An interventional study of Morning Bright Light Therapy in Brain Injuries, Traumatic and Post-traumatic Stress Disorder, sponsored by Portland VA Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-14.

Sponsored by Portland VA Medical Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Aug 2017, registered Jun 2018).
  • Started Aug 2017; still recruiting 9 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

One of the principal complicating factors associated with traumatic brain injury (TBI) is sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders). Morning bright light therapy (MBLT) has been shown to improve sleep quality in a variety of conditions, but little has been done investigating the utility of MBLT in improving sleep in Veterans with TBI. This proposal aims to determine the effect of MBLT on sleep quality in Veterans with TBI. Veterans with and without TBI will be recruited from the VA Portland Health Care System. Baseline questionnaires and 7 days of actigraphy will be collected prior to engaging in 60 minutes of MBLT daily for 4 weeks, during which actigraphy will also be collected continuously. Post-MBLT questionnaire data will be collected, and follow-up questionnaire data will be collected at 3 months post-MBLT.

02

Conditions studied

  • Brain Injuries, Traumatic
  • Post-traumatic Stress Disorder

Keywords

  • Sleep
  • Bright Light
03

In context

Brain Injuries, Traumatic

1,775 studies on the registry are indexed under Brain Injuries, Traumatic; 448 are open to participants now.

This study's planned enrollment of 200 is above the median of 56 across 1,133 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Portland VA Medical Center is the lead sponsor of 18 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Veterans

Exclusion criteria

Exclusion Criteria:

  • History of bipolar disorder
  • History of macular degeneration
  • Non-English speaking
  • Decisionally impaired
  • Currently using a light box
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Morning Bright Light Therapy

    Subjects who engage in morning bight light therapy

    Other: Morning Bright Light Therapy

  • No intervention
    Control

    Subjects who do not engage in morning bright light therapy

Interventions

  • OtherMorning Bright Light Therapy

    60 minutes of bright light therapy (10,000 lux) received within 90 minutes of waking

06

What researchers measure

Primary outcomes

  1. Change in Insomnia Severity Index (ISI)

    Measures self-reported insomnia severity; total score range = 0-28 (higher total score = worse insomnia)

    Time frame: Baseline; after 4 weeks of intervention; and 2 months after the end of intervention

07

Study locations

1 of 1 sites recruiting
  • VA Portland Health Care System
    Portand, Oregon 97239, United States
    • Miranda M Lim, MD, PhD · Contact · lmir@ohsu.edu · 503-220-8262
    Recruiting
08

References and documents

Publications

  • Elliott JE, McBride AA, Balba NM, Thomas SV, Pattinson CL, Morasco BJ, Wilkerson A, Gill JM, Lim MM. Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial. PLoS One. 2022 Apr 14;17(4):e0262955. doi: 10.1371/journal.pone.0262955. eCollection 2022. PubMed 35421086 ↗

Individual participant data

Plan to share: Yes — All non-identifiable data will be made available to qualified researchers on request to the study PI.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03578003
Lead sponsor
Portland VA Medical Center
Collaborators
Oregon Health and Science University
Responsible party
Miranda M Lim (Staff Physician and Assistant Professor, Portland VA Medical Center) — Principal investigator
First posted
Jul 5, 2018
Start date
Aug 2, 2017
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Nov 14, 2025

Study contacts

Miranda M Lim, MD, PhD
Contact
lmir@ohsu.edu
503-220-8262 ext. 57404
Jonathan E Elliott, PhD
Contact
elliojon@ohsu.edu
503-220-8262 ext. 58020
Miranda M Lim, MD, PhD
principal investigator · Portland VA Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion